• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA.

作者信息

Kamine J, Loewenstein P, Green M

机构信息

Institute for Molecular Virology, St. Louis University School of Medicine, Missouri 63110.

出版信息

Virology. 1991 Jun;182(2):570-7. doi: 10.1016/0042-6822(91)90598-6.

DOI:10.1016/0042-6822(91)90598-6
PMID:2024489
Abstract

We have utilized a gel retardation assay to study the binding of chemically synthesized domains of the HIV-1 Tat protein to radiolabeled trans-activating response element (Tar) RNA. As with recombinant Tat protein, synthetic Tat specifically binds to Tar RNA and not to a defective Tar RNA or to anti-sense Tar RNA. The 6 amino acid portion of the basic region containing five arginines is sufficient to confer Tar binding to overlapping Tat protein fragments; Tat fragments that lack the basic region do not bind Tar. In addition, the basic region alone can also bind Tar RNA; however, binding of the basic region is non specific since defective Tar RNA is bound as well as wild type Tar RNA. Binding specificity for wild type Tar RNA can be conferred by the addition of a minimum of 8 random amino acids to either end of the basic region.

摘要

相似文献

1
Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA.
Virology. 1991 Jun;182(2):570-7. doi: 10.1016/0042-6822(91)90598-6.
2
High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.人类免疫缺陷病毒1型反式激活蛋白(tat蛋白)与反式激活应答元件(TAR)RNA的高亲和力结合需要RNA茎中的碱基对以及碱性区域侧翼的氨基酸残基。
J Mol Biol. 1993 Mar 5;230(1):90-110. doi: 10.1006/jmbi.1993.1128.
3
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.Tat蛋白和Tat肽与1型人类免疫缺陷病毒反式激活应答序列元件在体外的序列特异性相互作用。
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8985-9. doi: 10.1073/pnas.87.22.8985.
4
Fragments of the HIV-1 Tat protein specifically bind TAR RNA.HIV-1反式激活因子(Tat)蛋白片段可特异性结合TAR RNA。
Science. 1990 Sep 14;249(4974):1281-5. doi: 10.1126/science.2205002.
5
tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.反式激活转录物(tat)调节人类免疫缺陷病毒反式激活区RNA环结合蛋白TRP-185的结合。
Genes Dev. 1991 Nov;5(11):2128-40. doi: 10.1101/gad.5.11.2128.
6
The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.人类免疫缺陷病毒1型TAR RNA的结构揭示了Tat蛋白识别RNA的原理。
J Mol Biol. 1995 Oct 20;253(2):313-32. doi: 10.1006/jmbi.1995.0555.
7
Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.人免疫缺陷病毒1型反式激活因子(tat)蛋白识别TAR RNA需要在大沟中形成氢键接触。
J Mol Biol. 1993 Mar 5;230(1):111-23. doi: 10.1006/jmbi.1993.1129.
8
Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.RNA聚合酶II与人免疫缺陷病毒反式激活区域RNA的特异性结合受细胞辅助因子和Tat调控。
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7153-7. doi: 10.1073/pnas.92.16.7153.
9
Selective binding of TAR RNA by a Tat-derived beta-peptide.
Org Lett. 2003 Oct 2;5(20):3563-5. doi: 10.1021/ol034977v.
10
Identification of a novel HIV-1 TAR RNA bulge binding protein.一种新型HIV-1 TAR RNA凸起结合蛋白的鉴定。
Nucleic Acids Res. 1994 Aug 25;22(16):3365-72. doi: 10.1093/nar/22.16.3365.

引用本文的文献

1
RNA binding by the herpes simplex virus type 1 nucleocytoplasmic shuttling protein UL47 is mediated by an N-terminal arginine-rich domain that also functions as its nuclear localization signal.单纯疱疹病毒1型核质穿梭蛋白UL47与RNA的结合由一个富含精氨酸的N端结构域介导,该结构域还作为其核定位信号发挥作用。
J Virol. 2007 Mar;81(5):2283-96. doi: 10.1128/JVI.01677-06. Epub 2006 Dec 13.
2
Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen.人类免疫缺陷病毒1型TAR RNA结合蛋白TRBP中的RNA结合基序与人类P1/dsI激酶和果蝇staufen的相关性。
Mol Cell Biol. 1993 Apr;13(4):2193-202. doi: 10.1128/mcb.13.4.2193-2202.1993.
3
Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
1型人类免疫缺陷病毒Tat对异源启动子的激活需要Sp1,且与酸性转录激活因子的激活模式不同。
J Virol. 1993 Nov;67(11):6828-34. doi: 10.1128/JVI.67.11.6828-6834.1993.
4
Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function.1型人类免疫缺陷病毒Tat功能辅助因子需求的遗传分析。
J Virol. 1993 Jul;67(7):3703-11. doi: 10.1128/JVI.67.7.3703-3711.1993.
5
Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.
Arch Virol. 1994;139(3-4):263-71. doi: 10.1007/BF01310790.
6
Bidirectional effectors of a group I intron ribozyme.I组内含子核酶的双向效应物。
Nucleic Acids Res. 1995 Apr 25;23(8):1284-91. doi: 10.1093/nar/23.8.1284.
7
NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus.马传染性贫血病毒反式激活应答(TAR)RNA元件的核磁共振分析。
Nucleic Acids Res. 1995 Oct 25;23(20):4058-65. doi: 10.1093/nar/23.20.4058.
8
Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter.一种与人类免疫缺陷病毒Tat蛋白结合并能增强病毒启动子反式激活作用的细胞蛋白的分离。
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8875-9. doi: 10.1073/pnas.88.20.8875.
9
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.人免疫缺陷病毒1型Tat蛋白通过Sp1依赖性激活合成启动子。
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8510-4. doi: 10.1073/pnas.88.19.8510.
10
Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).人类免疫缺陷病毒1型转录反式激活因子(HIV-1 Tat)的随机诱变
Nucleic Acids Res. 1992 Oct 25;20(20):5311-20. doi: 10.1093/nar/20.20.5311.